Vitrisa Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 3

% Expired Patents = 33.3

Forward Citations = 10

Loading Chart...

6 inventors (with patents filed for the assignee):

Carl Erickson (3 out of 7 patents)

Christopher P Rusconi (3 out of 26 patents)

Kevin G McLure (3 out of 6 patents)

4. Arijit Bhowmick (1 out of 3 patents)

5. Matthew Levy (1 out of 11 patents)

6. Renta Hutabarat (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 10428330 - Stem-loop compositions and methods for inhibiting factor D (2019-10-01),

2. 10308943 - Compositions with improved intravitreal half-life and uses thereof (2019-06-04),

3. 10174325 - Compositions and methods for inhibiting Factor D (2019-01-08),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

3 Patents

#977 in San Jose, CA

#16,875 in California

#73,929 in US

San Jose, CA, United States of America

Vitrisa Therapeutics, Inc.

Forward Citations = 10

6 inventors:

Carl Erickson (3 out of 7 patents)

Christopher P Rusconi (3 out of 26 patents)

Kevin G McLure (3 out of 6 patents)

4. Arijit Bhowmick (1 out of 3 patents)

5. Matthew Levy (1 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vitrisa Therapeutics, Inc.. Retrieved from https://idiyas.com/company/vitrisa-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]